Study drug LOXO-101 shrinks several types of tumor
Monday, April 18, 2016 - 09:40
in Health & Medicine
Stephen FellerNEW ORLEANS, April 18 (UPI) -- A drug called LOXO-101 caused significant regression in various types of cancer among patients in a recent clinical trial, according to researchers.